๐Ÿ›๏ธ Verified NIH Record โ€ข Updated 2025-11-12

Improving Colonoscopy Surveillance for Patients With High Risk Colon Polyps (NCT06376565)

Multilevel Health System Intervention to Increase Guideline-Concordant Surveillance Colonoscopy for High Risk Colon Polyps

๐ŸŸข Recruiting Observational / Diagnostic ๐Ÿ“‹ Clinical Research Protocol Sponsor: Jonsson Comprehensive Cancer Center

๐Ÿฉบ Plain-English Summary (8th-Grade Level)

This clinical trial tests a multilevel intervention at the clinic, provider and patient levels, to improve colonoscopy surveillance in patients with high risk colon polyps. Colorectal cancer (CRC) is a common and deadly disease that is largely preventable through the detection and removal of colorectal polyps. One million Americans are diagnosed with high risk polyps of the colon or rectum annually and are at increased risk for CRC; however, uptake of recommended repeat colonoscopy in 3 years to reduce CRC risk is low in this group. This multilevel intervention may work to improve timely colonoscopy screening for patients with high risk colon polyps.

Who can join: Review the eligibility criteria below.

Location: UCLA / Jonsson Comprehensive Cancer Center โ€” Los Angeles, California

Age range: 21 Years

๐Ÿงช Interventions in This Study

  • Best Practice (OTHER)
  • Communication Intervention (OTHER)
  • Communication Intervention (OTHER)
  • Communication Intervention (OTHER)
  • Interview (OTHER)
  • Interview (OTHER)

๐Ÿ“‹ "Do I Qualify?" โ€” 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria โ†—

๐Ÿ“ All Participating Trial Locations (1 Sites)

  • UCLA / Jonsson Comprehensive Cancer Center โ€” Los Angeles, California

๐Ÿ“ž Contact the Study Coordinator

Phone: (310) 794-6197

Email: JCAlarcon@mednet.ucla.edu

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

๐Ÿ’ฐ Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

๐Ÿ’ก How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Contact the study coordinator using the phone/email above.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
๐Ÿ›๏ธ View Official NIH Record โ†—